Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
| Actual shortage: | 240 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
27 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-08-29 | 2019-11-08 | 92672 |
| TEVA-IRBESARTAN | 150MG | TABLET | Resolved | 2019-09-19 | 2021-09-10 | 94369 |
| ACT RANITIDINE | 150MG | TABLET | Resolved | 2019-09-26 | 2020-05-14 | 94846 |
| ACT RANITIDINE | 150MG | TABLET | Resolved | 2019-09-26 | 2020-05-14 | 94849 |
| ACT RANITIDINE | 150MG | TABLET | Resolved | 2019-09-26 | 2020-05-14 | 94852 |
| TEVA-LACOSAMIDE | 150MG | TABLET | Resolved | 2019-10-03 | 2019-10-10 | 95387 |
| ACT RANITIDINE | 150MG | TABLET | Resolved | 2020-01-24 | 2020-05-14 | 104307 |
| TEVA-LACOSAMIDE | 150MG | TABLET | Resolved | 2020-01-30 | 2020-04-02 | 104899 |
| TEVA-SULINDAC | 150MG | TABLET | Resolved | 2020-03-06 | 2020-03-26 | 107967 |
| TEVA-QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-03-06 | 2020-05-21 | 107986 |
| TEVA-PREGABALIN | 150MG | CAPSULE | Resolved | 2020-04-10 | 2020-04-23 | 111854 |
| TEVA-TRAZODONE | 150MG | TABLET | Resolved | 2020-04-16 | 2020-05-21 | 112385 |
| TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-05-01 | 2020-05-08 | 113726 |
| TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-07-09 | 2020-08-27 | 119889 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-07-09 | 2023-04-28 | 119904 |
| TEVA-TRAZODONE | 150MG | TABLET | Resolved | 2020-08-20 | 2020-09-03 | 122699 |
| TEVA-CLINDAMYCIN | 150MG | CAPSULE | Resolved | 2020-08-20 | 2021-01-28 | 122702 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-09-03 | 2020-09-24 | 123741 |
| NV-CLINDAMYCIN | 150MG | CAPSULE | Resolved | 2020-09-24 | 2020-10-08 | 124959 |
| TEVA-SULINDAC | 150MG | TABLET | Resolved | 2020-09-24 | 2020-11-07 | 124998 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |